Abstract Recent studies have revealed that angiotensin II (Ang II) interacts with two pharmacologically different types of seven-transmembrane domain receptors, hence named Ang II type 1 and type 2 (AT, and AT 2 ) receptors. cDNAs for the AT, receptor have been cloned, and the existence of two receptor subtypes, AT, A and AT 1B , has been revealed in rat and mouse. This study presents a new approach for the specific quantification of AT, A and AT, B receptor mRNAs by reverse transcription and polymerase chain reaction amplification in the presence of an AT, receptor mutant cRNA as internal standard. Absolute quantities of mRNA are then determined by extrapolation using the standard curve generated with the internal standard. Moreover, addition of this internal standard to each tube controls for both reverse transcription and polymerase chain reaction amplification in each sample. In male Wistar rats, the highest absolute AT, A receptor mRNA levels were found in liver and kidney and those for AT 1B receptor mRNA in the pituitary. Expressed as a percentage of total AT, A +AT, B A ngiotensin II (Ang II) is a biologically active peptide of the renin-angiotensin system that produces vasoconstriction, aldosterone secretion, catecholamine release, thirst, and prolactin and corticotropin secretions as well as stimulates hypertrophy of vascular smooth muscle cells. © 1994 American Heart Association, Inc.
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Abstract Recent studies have revealed that angiotensin II (Ang II) interacts with two pharmacologically different types of seven-transmembrane domain receptors, hence named Ang II type 1 and type 2 (AT, and AT 2 ) receptors. cDNAs for the AT, receptor have been cloned, and the existence of two receptor subtypes, AT, A and AT 1B , has been revealed in rat and mouse. This study presents a new approach for the specific quantification of AT, A and AT, B receptor mRNAs by reverse transcription and polymerase chain reaction amplification in the presence of an AT, receptor mutant cRNA as internal standard. Absolute quantities of mRNA are then determined by extrapolation using the standard curve generated with the internal standard. Moreover, addition of this internal standard to each tube controls for both reverse transcription and polymerase chain reaction amplification in each sample. In male Wistar rats, the highest absolute AT, A receptor mRNA levels were found in liver and kidney and those for AT 1B receptor mRNA in the pituitary. Expressed as a percentage of total AT, A +AT, B A ngiotensin II (Ang II) is a biologically active peptide of the renin-angiotensin system that produces vasoconstriction, aldosterone secretion, catecholamine release, thirst, and prolactin and corticotropin secretions as well as stimulates hypertrophy of vascular smooth muscle cells. led to the identification of two major receptor subtypes, designated AT, and AT 2 . These two subtypes bind Ang II and its peptide analogues with the same affinity. AT, receptors have a high affinity for DuP 753. They are coupled to stimulation of inositol phospholipid hydrolysis with subsequent mobilization of intracellular Ca 2+ and in some tissues to either inhibition or stimulation of adenylate cyclase via a pertussis toxin-sensitive G protein 57 AT 2 receptors have a high affinity for PD 123177. On the functional level, AT, receptors mediate those classic functions assigned to Ang II above, whereas the function of the AT 2 receptor remains uncertain.
and AT 1B receptors is the presence in the former, at position 355, of a cysteine residue that can be modified by thioesterification with palmitic acid. This constitutes an important posttranslational modification, which mediates the functional coupling of the receptor to its effector proteins.
Expression of AT 1A and AT 1B in COS-7 cells has shown that there is very little difference between these two subtypes concerning the binding of Ang II analogues and the use of Ca 2+ as an intracellular second messenger. Indeed, only two differences have been noted at these levels. First, Ang I was 10-fold less potent in displacing 125 I-Ang II from the AT 1B receptor than from the AT 1A receptor. 919 Second, in Xenopus oocytes injected with AT 1B or AT 1A mRNA, Ang II elicited a large increase in intracellular Ca 2+ concentrations that was reduced at high Ang II concentrations in the case of the AT 1B receptor but not in that of the AT 1A receptor, probably reflecting a different desensitization pattern for these two receptor subtypes. 20 Third, an important difference between AT, receptor subtypes occurs at the level of their tissue distribution and differential regulation, 18 -23 - 24 suggesting that these receptor subtypes could mediate different physiological functions.
To estimate the degree of expression of each subtype in various organs and to determine their regulation under pathophysiological conditions, we developed a quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) amplification method coupled to enzymatic digestion, allowing precise quantification of AT, A and AT 1B mRNA levels. We were therefore able to define absolute AT 1A and AT 1B receptor mRNA levels in different organs. This approach was validated by the finding of a parallel increase in Ang II (AT,) binding capacity and AT, A and AT, B mRNA expression in rat adrenals after salt depletion, a condition associated with profound stimulation of the renin-angiotensin system. Finally, we examined the regulation of adrenal AT, A and AT, B receptor gene expression in an experimental model of renovascular hypertension (two-kidney, one clip [2K1C] rats).
Methods

Animal Procedures
This study was conducted in accordance with current guidelines for the care and use of experimental animals.
Male Wistar rats (250 g) were obtained from Iffa Credo. In the study concerning the distribution of AT 1A and AT 1B mRNA levels among various tissues, rats were killed by decapitation, and the different organs were removed and immediately frozen in liquid nitrogen before storage at -80°C until use.
Sodium Depletion
Rats were divided into two groups and fed for 8 days with low sodium (0.02%) rat chow (UAR). The water of control rats contained 0.3% sodium. All animals had free access to food and water. At the end of the 8 days, the rats were killed by decapitation at 2 PM, and their adrenals were removed and stored as described above. For estimation of Ang II levels, blood was collected into tubes kept on ice at 4°C containing 6.25 mmol/L EDTA, 10 mmol/L SR43845 (a renin inhibitor), and 10 /j,mol/L MK422 (a specific angiotensin-converting enzyme inhibitor).
Renovascular Hypertension
Rats were given sodium pentobarbital (40 mg/kg body wt IP) for anesthesia before undergoing surgical procedures. After laparotomy, a 0.2-mm silver clip was placed on the left renal artery. The right kidney and renal artery were left intact and unmanipulated. During the experimental period, the animals were given free access to tap water and normal rat chow, and systolic blood pressure was measured once a week by the tail-cuff method (W+W electronic recorder 8005, Apelab). Six weeks after surgery, rats were killed, adrenals were removed, and plasma was collected for renin activity measurement.
RNA Preparation
Total RNA was extracted by the acid guanidinium thiocyanate-phenol-chloroform method of Chomczinski and Sacchi. 25 The quality of isolated mRNA was checked by gel electrophoresis. For this purpose, 2 jj.g total RNA was denatured in a mixture containing 50% formamide and 20% formaldehyde for 10 minutes at 65°C. The denatured RNA was fractionated by gel electrophoresis on a 1% agarose gel containing 10% formaldehyde, stained with ethidium bromide, and photographed under UV light using Polaroid 665 film. The negative was scanned through the 28S and 18S ribosomal bands to quantify the relative amount of total RNA in each tissue by comparison with an internal standard of known concentration (RNA ladder, BRL).
Internal Standard Preparation
An internal standard was synthesized by in vitro transcription of the plasmid BSd AT, A containing the entire coding sequence of the rat AT 1A receptor (nucleotides -182 to 1935) except for a 63-nucleotide deletion (nucleotides 502 to 564 according to Murphy et al 9 ) containing the EcoRI restriction site. The deleted AT 1A receptor cRNA was obtained from this plasmid by using T7 RNA polymerase after the template had been linearized with the restriction enzyme Sal I. After the reaction, the template DNA plasmid was digested by RNasefree DNase I. The cRNA was purified by guanidinium isothiocyanate-phenol-chloroform extraction and isopropanol precipitation, and its concentration (1.13 /umol/L) was determined by its optical density at 260 nm.
Choice of Primers
Oligonucleotide primers were chosen in homologous parts of the coding region of the rat AT, A and AT 1B receptor genes. Two reverse primers (b: 5'-GCA CAA TCG CCA TAA TTA  TCC-3', position 739-719 bp, and c: 5'-GGC GAA GGC GAG  ACT TCA TT-3', position 418-399 bp) and a sense primer (a:  5'-CAC CTA TGT AAG ATC GCT TC-3', position 295-314  bp, according to Murphy et al   9   ) were synthesized using a PCR-mate 391 device (Applied Biosystems). 
Reverse Transcriptase Reaction
PCR Amplification
Double-stranded cDNAs were synthesized and amplified using 2.5 U Taq polymerase (Boehringer) and 80 nmol/L primers in 0.05 mL of 10 mmol/L Tris-HCl buffer (pH 8.3), 50 mmol/L KC1, 2.0 mmol/L MgCl 2 , 0.5 mmol/L dNTP, 2 mmol/L dithiothreitol, and 0.01% gelatin for 30 cycles at 92°, 54°, and 72°C for 60, 60, and 90 seconds, respectively. Since the coding regions of the rat AT, A and AT 1B receptor genes are composed of only one exon, contamination of sample RNAs by genomic DNA was excluded by directly subjecting the sample RNAs to PCR amplification without an RT step. Under these conditions, samples in which a DNA PCR product was seen were eliminated. A trace amount of [ 3 H]a-dCTP (3 piCi) was included in the PCR reaction for quantification of the different PCR products, with the number of C residues present in each fragment (AT 1A =117, AT 1B =113, internal standard=105) taken into account. After PCR amplification, the PCR products were submitted to EcoRl digestion (2000 U/^-L) for 90 minutes at 37°C in order to distinguish AT 1A RNA PCR products from those of AT 1B . The digestion efficiency was verified in each experiment by the observation of a complete digestion of a PCR product arising from the amplification of the AT 1A cDNA. The different PCR products were separated on a 1.5% agarose gel for visual verification and on a 5% polyacrylamide gel for precise quantification. The bands were excised, solubilized in 0.025 mol/L periodic acid at 50°C, and counted by liquid scintillation spectrometry (Picofluor, Du Pont-New England Nuclear).
The yield of each RT-PCR amplification reaction was evaluated by the radioactivity incorporated into the PCR product of the synthetic RNA (added in trace amounts to each wildtype RNA analyzed).
Finally, a standard curve was generated with the internal standard, allowing the expression of AT, receptor mRNA levels from various tissues as molecules of synthetic RNA per microgram of total RNA.
Southern Blot Analysis
To verify that the amplified fragments corresponded to authentic AT, receptor transcripts, we hybridized Southern blots of electrophoresed PCR products with the c oligonucleotide located inside the synthesized cDNA sequence. PCR products were electrophoresed on 1.5% agarose gels and blotted on N Hybond membranes (Amersham). Filters were prehybridized at 42°C for 2 hours and hybridized at 42°C for 16 hours in 6x saline sodium citrate buffer (SSC), 50 mmol/L NaH 2 PO 4 buffer (pH 7.0), 0.1% sodium dodecyl sulfate (SDS), 5x Denhardt's solution, and 0.1 mg denaturing salmon sperm DNA per milliliter, with the addition of 32 P-labeled oligonucleotide (obtained with polynucleotide kinase) at 2X10 6 disintegrations per minute per milliliter for the hybridization. Filters were washed at room temperature for 20 minutes in 6X SSC and 0.1% SDS and then twice for 15 minutes at 47°C in 2X SSC and 0.1% SDS. Autoradiography was performed at -80°C using Kodak X-OMAT film with intensifying screens.
Plasma Ang II Levels and Renin Activity Measurement
Plasma immunoreactive Ang II levels were measured using a monoclonal antibody (MAb 4D8) according to a previously described method. 26 Plasma renin activity was measured according to the method of Menard and Catt. 27 
Binding Assay
Tissues were homogenized in 50 mmol/L Tris-HCl buffer, pH 7.4, containing 1 mg/mL bacitracin and 1 mmol/L EDTA (1:20 wt/vol) with six to 10 strokes of a mechanical homogenizer. Homogenates were centrifuged at lOOOg for 10 minutes. The supernatant was centrifuged at 60 OOOg for 60 minutes and the pellet resuspended in 50 mmol/L Tris-HCl buffer, pH 7.4, containing 140 mmol/L NaCl, 6.5 mmol/L MgCl 2 , 2 mg/mL bovine serum albumin, and 1 mg/mL bacitracin for the subsequent binding assay. for 60 minutes at 25°C and terminated by the addition of 4 mL ice-cold Tris-HCl buffer to each tube followed by immediate filtration through Millipore nitrocellulose RAWP filters (1.2 fim) and two additional washings with 4 mL Tris-HCl buffer. The filter-bound radioactivity was counted in a gamma spectrometer. Receptor affinity and concentration were calculated by Scatchard analysis of the binding data using the computerized curve-fitting program LIGAND.
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Protein Determination
Protein content was determined according to Lowry et al 29 using bovine serum albumin as the standard.
Statistical Analysis
Differences in biological parameters were evaluated by onefactor ANOVA followed by the Scheffe F test for comparison of the effect of different pathophysiological conditions on these parameters.
Results
Schematic Representation of RT-PCR Amplification Approach Used To Estimate AT 1A and AT 1B Receptor mRNA Levels
To specifically determine the transcript of the AT, A and AT 1B receptor genes, we performed RT-PCR amplification of total RNAs between the two primers a and b, which were common to the two subtypes and present in the coding region of each. The RT reaction was carried out by using the specific reverse primer b.
After PCR amplification of the cDNA, we obtained for each transcript a PCR product of 444 bp (Fig 1) . These products could then be differentiated by their size after submission to EcoRl digestion. EcoRl did not affect the AT, B PCR product but hydrolyzed that of AT, A into two fragments of 269 and 175 bp, respectively (Fig  1) . On the other hand, the RT-PCR amplification of the synthetic RNA (internal standard) between a and b resulted in the formation of a PCR product of 384 bp, the smaller size being due to the 63 bp deletion that included the EcoRl restriction site. This 384 bp PCR product was therefore insensitive to EcoRl digestion.
To illustrate the results of this approach visually, we amplified the cDNAs encoding AT, A and AT 1B receptor subtypes and the internal standard between the primers a and b for 30 cycles. PCR products were submitted to EcoRl digestion and electrophoresed on an agarose gel. Fig 1 shows that digestion is complete in the case of the AT, A PCR product but does not occur for AT 1B and internal standard PCR products.
In addition, total RNA from various organs was reversetranscribed, amplified between a and b, and submitted to EcoRl digestion. Features identifying the amplified products as AT 1A and AT 1B receptor transcripts were their size, their sensitivity to EcoRl digestion, and their positive hybridization with the 32 P-labeled oligonucleotide c (1) located in the amplified sequence, (2) derived from the rat AT 1A receptor cDNA sequence, and (3) 95% homologous with rat AT 1B cDNA sequence (Fig 2) .
AT 1A PCR products were qualitatively present in all the studied organs, whereas AT 1B PCR products appeared in aorta, brain, and the adrenals without being detectable in liver or mesenteric artery.
Quantitative Analysis
Linearity of PCR Amplification Reaction
The liver, which possessed the highest content of AT, receptor mRNA, was used to produce cDNA by RT and to test the linearity of PCR product accumulation with increasing number of cycles. Aliquots containing one tenth of the cDNA mixture each were subjected to between 26 and 35 cycles of amplification under the conditions described in "Methods." The amount of radioactivity recovered from the excised bands was plotted as a function of the number of cycles. Fig 3 shows that the amplification rate of the template was exponential between 26 and 32 cycles. At 34 cycles and above, the rate decreased drastically and approached a plateau (data not shown). The efficiency of amplification (eff) was calculated from the slopes of the curve according to the equation N=No(l+eff) n , where No is the initial amount of material, n is the number of cycles, and N is the extent of amplification. It was found to be 90%. Amplification efficiency was the same when the internal standard cDNA was the target used (Fig 3) , as demonstrated by the identity of the slopes of the curves corresponding to target and internal standard PCR product accumulation (slopes, 0.258 and 0.269, respectively). AJl experiments were performed at 30 cycles whatever the organ used, because this was still in the exponential phase, and the radioactive signal was strongly detected.
RT-PCR Standard Curve Using Synthetic cRNA as Template
Different amounts of cRNA were reverse-transcribed using the specific reverse primer b and amplified between primers a and b for 30 cycles of PCR in the presence of [ 3 H]a-dCTP (Fig 4) . In the range of 0.3 to 25X10 5 molecules of the internal standard, a linear relation was observed between the radioactivity incorporated into the PCR product and the pre-PCR amount of RNA. This linearity occurred over a range of six 1:2 dilutions. The detection limit of this assay was approximately 50 fg, equivalent to 3x10" molecules.
In addition, in Fig 4, several 1:2 dilutions of liver RNA (4 to 100 ng), containing only the AT 1A receptor subtype, and adrenal RNA (30 to 500 ng), containing both AT, A and AT 1B receptor subtypes, were plotted against the radioactivity yielded by corresponding PCR products under the same conditions as described for the cRNA. The fact that the liver RNA (AT 1A ) and adrenal RNA (ATi A and AT 1B ) dilution curves were parallel to that of the internal standard suggests not only that the PCR amplification efficiency was identical for the target and internal standard RNAs (as shown in Fig 3) but also that the RT efficiency was quite similar in this range of dilutions. This allowed the construction of a standard curve for cRNA and the determination by extrapolation of the number of copies of AT, receptor mRNA present in the liver or adrenals. As shown in Fig 4, 20 ng of liver RNA and 3.2X10 5 molecules of internal standard gave the same amount of PCR product.
Quantitative RT-PCR Amplification ofAT, A and AT IB Receptor mRNAs in Liver and Adrenals
To be able to quantify the AT, receptor transcripts by RT-PCR amplification, we needed to coamplify the target mRNA and internal standard (cRNA). One of the difficulties of this approach is the necessity to determine the concentration of the internal standard to be added to the wild type to avoid competition between endogenous and synthetic RNAs during the RT-PCR amplification.
Two organs were studied in detail for this purpose: the liver, which contains only the AT 1A receptor subtype, and adrenal glands, which contain both receptor subtypes.
Liver. Different amounts (5 to 25 ng) of liver total RNA were reverse-transcribed and amplified as described above in the presence or absence of 2xlO 5 molecules of synthetic RNA. A linear relation between the radioactivity incorporated into the AT 1A receptor PCR product (converted into molecules of mRNA according to the standard curve) and the amount of liver RNA was observed in both the absence and presence of 2X10 5 molecules of the internal standard (Fig 5) . The absence of competition between endogenous and synthetic RNAs was shown by the fact that curves obtained in the presence or absence of internal standard were parallel and their slopes not significantly different (see Fig 5) . Moreover, the synthetic RNA was RT-PCRamplified with the same efficiency as in the range of liver RNA concentrations used, demonstrating the identical yield of the RT-PCR amplification reactions for each liver sample (whatever the concentration studied).
Adrenals. Experiments similar to those described for the liver were performed with adrenals but were followed by submission to EcoRI digestion to differentiate the PCR products corresponding to the two receptor subtypes (ATlA and ATlB). After RT and 30 PCR cycles, a linear relation between the radioactivity incorporated into the ATlA and ATlB receptor PCR products and the initial amount of total RNA was observed from 0.05 to 0.5 pg of adrenal total RNA (Fig 6) . The curves obtained for AT,, and AT,, RNA were parallel and linear over this concentration range.
As was true for liver AT,, receptor RNA quantification, the addition of 2x105 molecules of internal standard to adrenal RNA did not change the efficiency of the RT-PCR amplification, in this case true for either receptor subtype RNA. This is shown by the fact that the slopes of the curves obtained for AT,, (Fig 6, left) and AT,, (Fig 6, right) RNAs were not significantly different in the presence or absence of the internal standard. Furthermore, over the range of adrenal RNA concentrations studied, each synthetic RNA was RT-PCRamplified with the same efficiency, demonstrating again an equal yield for the RT-PCR reaction in each sample. Fig 7 shows the visualization of the amplified cDNA products generated from ATlA and ATlB receptor subtype mRNAs in various tissues of control rats. For each tissue, a series of RNA dilutions was first studied. Only one of the dilutions in which the generation of a PCR product was still in the exponential range, and in which the RNA did not compete with the internal standard, is shown. ATlA and ATlB receptor mRNA levels were differentially distributed. AT,, receptor mRNA was expressed in high amounts in liver, and AT,, was not detectable. ATlA receptor mRNA was also the main form expressed in lung, aorta, and kidney, whereas in whole adrenals, AT,, and AT,, receptor mRNAs were expressed equally. Careful separation of adrenal cortex to medulla before the mRNA was processed showed a differential pattern of AT, receptor mRNA distribution: in the cortex, there was 58% AT,, receptor mRNA versus 42% for AT,,, whereas in the medulla, there was 30% AT,, receptor mRNA versus 70% for ATlA. AT,, receptor mRNA was predominantly expressed in pituitary only, where ATlA was hardly detectable. The presence of the internal standard allowed calculation of the ]a-dCTP. PCR products were electrophoresed and visualized under UV light after ethidium bromide staining. Bands were excised and counted, and radioactivity was plotted against cRNA concentrations. In parallel, several 1:2 dilutions of liver or adrenal total RNA were analyzed using the same procedure, except that adrenal PCR products were submitted to EcoRI digestion before electrophoresis. Each point represents mean±SEM of three to five separate experiments, with less than 10% variation between experiments. Int. Std. indicates internal standard.
Quantitative Distribution of AT,, and AT,, Receptor mRNA Levels in Various Rat Tissues
absolute amounts of these mRNAs (molecules per microgram total RNA) ( Table 1) .
Modulation of Adrenal AT, Receptor mRNA Levels
Effect of sodium depletion on rat adrenal AT, receptor mRNA levels. As an application of this method of AT, receptor mRNA quantification, the effect of sodium deprivation on adrenal AT 1A and AT 1B receptor mRNA levels was studied. The results are shown in Effect of renovascular hypertension. At the time of death, systolic blood pressure was significantly higher in the 2K1C group (238 ±8 mm Hg) than in the control group (138±4 mm Hg). The increase in systolic blood pressure in 2K1C animals was accompanied by an elevation of plasma renin activity (+180%), as shown in Table 3 . Adrenal AT, B receptor mRNA levels were halved in the 2K1C rats compared with control rats, whereas no significant difference was found for AT, A receptor mRNA levels (Fig 8, Table 3 ).
Discussion
The quantification of mRNAs from isoforms of seventransmembrane, G protein-coupled receptors raises a 3 H]adCTP. PCR products (one fifth of the PCR reaction) were electrophoresed and visualized under UV light after ethidium bromide staining. The varying template concentrations of liver total RNA were plotted against the radioactivity of their PCR products (converted into molecules according to the standard curve). Each point represents mean±SEM of three to five separate experiments. A photograph of the gel before band excision is shown above and below the graphs corresponding to each set of experimental conditions. Int. Std. indicates internal standard.
few difficult methodological problems. Indeed, these receptors have a relatively low level of expression, and the isoform coding regions may be very similar, as has been shown for the isoforms of the dopamine receptor and somatostatin or muscarinic receptors. Although differences in the 3'-or 5'-untranslated regions can be exploited for specific mRNA amplification, this strategy is questionable because of the use of alternate promoters or polyadenylation sites. AT 1A and AT 1B receptor mRNA quantification raises such problems because, for example, exon 2 of the AT 1A receptor 5' noncoding region is transcribed or not according to tissues. Therefore, a new approach had to be developed to specifically quantify the mRNA of these two receptor isoforms.
The approach presented here of quantitative RT-PCR coupled to restriction endonuclease digestion can accurately determine absolute quantities of the low abundance of AT 1A and AT, B receptor mRNAs in different organs. The detection limit of the RT-PCR amplification the absence of an intron in the coding region. It is based on the use of primers from homologous parts of the coding regions and differentiation of the respective PCR products by submitting them to restriction endonuclease digestion by EcoRI, for which a restriction site is present in the AT, A cDNA but not in the AT 1B cDNA. The completeness of the digestion must be checked in each reaction by the parallel digestion of an AT 1A cDNA amplicon. EcoRI digestion needed to be used in the exponential phase of the PCR reaction; if not (for example, if used in the plateau phase), the DNA strands not used as templates could reassociate and form heterodimeric DNA species 30 that would not be cut by EcoRI. Although necessary, working in the exponential phase imposes severe practical constraints, because only a few cycles are available in the late exponential phase, ie, from the point at which PCR products became visible or detectable on the gel to the onset of the nonexponential phase. Recently, other authors 3132 developed the quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation, thereby considerably simplifying the assay; this technique clearly could not be used in our study. Furthermore, the use of common primers for RT-PCR amplification of AT 1A and AT, B mRNA and the high homology between their corresponding cDNA sequences are sources of competition during the PCR amplification. For each tissue, RNA dilutions followed by RT-PCR amplification had to be performed to define the range of concentrations at which the two mRNAs would be RT-PCR-amplified without competition. This range depended on the abundance of each RNA wild type. The absence of an intron in the AT, receptor gene poses the problem of the exact nature of the template for the RT-PCR amplification, because both mRNA and genomic DNA would give amplicons of identical size. To avoid the possibility of genomic DNA contamination, we submitted each sample to PCR amplification without the RT reaction. Positive reactions suggested genomic contamination and were omitted. However, these conditions did not allow us to work on tissue lysates, and RNA extraction was necessary to obtain "pure" RNA devoid of genomic DNA.
The concept of the present quantitative approach is similar to those approaches described by Becker-Andre and Hahlbrock 30 and Gilliland et al. 33 These methods consist of the use of an internal standard, a cRNA with the same sequence as the cellular template except for (1) the presence of a small deletion (in our case, 63 bp, which included the EcoRl restriction site) or of a small intron or (2) the creation of a restriction enzyme site, permitting size separation of the standard and target RNA PCR products.
The most commonly used quantitative RT-PCR method is the competitive RT-PCR, 3336 in which a given amount of target total RNA and internal standard cRNA are combined and reverse-transcribed into cDNAs. Serial dilutions of the cDNA mixture are PCRamplified, and the amount of mRNA is then measured by extrapolation using the standard curve generated with the internal standard. Another possibility is to reverse transcribe target and internal standard RNAs separately and then to add a constant quantity of the target cDNA to different dilutions of the internal standard cDNA. After PCR amplification, the respective PCR products of the target and internal standard RNAs are quantified. Only one sample will contain equal amounts of both types of DNA, reflecting equal amounts of the corresponding RNA species. In these approaches, the main limitation is the assumption that the RT efficiency (generally 45% to 50% as described by Elalouf et al 37 and Paul et al 38 ) is identical for the target and internal standard mRNAs and does not vary with the RNA amount submitted to the reaction.
To overcome this limitation, the present strategy involves separate RT of different amounts of target mRNA or internal standard cRNA and PCR amplification of the corresponding cDNAs at a fixed number of cycles, where the PCR amplification is in the exponential phase. The PCR product quantity was a direct function of the amount of RNA introduced in the RT. Furthermore, dilutions of target RNA after RT-PCR amplification resulted in a curve parallel to that obtained starting from the different dilutions of the internal standard cRNA (Fig 4) . These results suggest not only that the PCR amplification efficiency is identical for target and AT 1A and AT 1B indicate angiotensin receptor subtypes 1A and 1B; Ang, angiotensin. After 8 days on a low sodium diet, five control and five treated animals were killed. Plasma Ang II levels were measured by radioimmunoassay using a specific monoclonal antibody. One adrenal was used for binding studies, the other for measurement of AT, A and AT, B receptor mRNA levels. For each animal, 1.0 and 0.5 /ig of adrenal total RNA, combined with 8X10 5 molecules of internal standard cRNA were reverse-transcribed, and one quarter of the cDNA mixture was PCR-amplified as described in Fig 7. After EcoRl digestion, PCR products were electrophoresed and bands excised to measure radioactivity. Total RNA for each animal was separated on a denaturing formaldehyde gel, and 18S and 28S ribosomal bands were visualized under UV light and scanned for estimation of total RNA. internal standard RWAs, as shown by the identity of the accumulation rates of their respective PCR products over increasing cycle numbers, but also that there is an equal RT efficiency of these two templates. This allowed the construction of a standard curve with the internal standard cRNA and the determination by extrapolation of the number of copies of AT 1A and/or AT 1B mRNA present in the tissues studied.
To evaluate AT, mRNA levels in tissues from control or treated animals, it is important to verify the yield of the RT and PCR amplification reactions in each tube. Thus, the internal standard cRNA was added in trace concentrations to each of the unknown samples, reversetranscribed, and PCR-amplified concomitantly with the target RNA, providing an internal control of the conditions of RT-PCR amplification. The amount of internal standard added depended on the abundance of the target mRNA in the tissue studied. Preliminary studies had to be carried out to define precisely the amount of internal standard that would not produce any competition with the coamplified target mRNA, whatever the concentration of target mRNA tested. Fig 5 showed that the RT-PCR amplification of different dilutions of liver RNA in the presence or absence of internal standard gave two curves with identical slopes. This experiment became more complex when both receptor subtype mRNAs had to be estimated concomitantly, eg, in the adrenals. In this case, the target RNA concentration range that could be used was more restricted. A rigorous control, similar to that reported in this study for liver and adrenal AT 1A and AT 1B receptors, must be performed for each organ.
Quantitative RT-PCR is a powerful approach that allows the investigator to measure a wide range of target mRNA using a small amount of material. However, it is important to note that this methodology is limited by the fact that it does not identify the cell type in which mRNA expression has been altered, nor does it necessarily reflect the level of expression of the protein product of a target gene. Therefore, it would be most advantageous to use quantitative RT-PCR along with other methods such as in situ hybridization, immunohistochemistry, or radioligand binding assay.
The development of this RT-PCR approach allowed us to determine absolute quantities of AT 1A and AT 1B mRNA in different organs. AT 1A mRNA is predominant in liver, lung, kidney, and aorta, and AT 1B mRNA in the pituitary; they were present in equal proportions in whole adrenals. Several groups' 8-20,23,24 n a v e studied the distribution of AT 1A and AT 1B receptor mRNA levels in different tissues, but subtype mRNA proportions often differ between studies, probably reflecting the use of nonquantitative RT-PCR methods. In the present study, absolute mRNA levels were very different for the two receptor subtypes, the AT 1A mRNA being the most abundant.
There is good correlation between AT 1A and AT 1B mRNA levels and the maximal AT] receptor density in studied organs 39 
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41 except for the pituitary, in which the mRNA content is relatively higher compared with the protein level. This could indicate a slower turnover rate for the mRNA than for the protein. Given that Ang II receptor stimulation induces an increase in prolactin and in corticotropin secretion, 4243 this reserve of mRNA could allow lactotrope-and corticotrope-secreting cells, which express AT, receptors at their surface, 44 - 45 to respond rapidly to biological stimuli such as suckling or stress. In addition, this RT-PCR approach was used to investigate alterations in adrenal AT, A and AT 1B mRNA expression in two well-defined pathophysiological situations: low sodium diet and renovascular hypertension. Low sodium diet increased both receptor subtype mRNA levels in the adrenal; an increase in the number of adrenal AT, binding sites was also found. This latter Definitions are as in Table 2 . Animals were killed 6 weeks after surgery. Plasma was collected for renin activity measurement as described in "Methods." Blood pressure was measured just before death. Adrenal AT, A and AT, B mRNA levels were estimated as described in Fig 8. Values are mean±SEM.
by guest on July 12, 2017 http://hyper.ahajournals.org/ Downloaded from result is compatible with the well-known effects of sodium depletion, which induces hyperactivity of the renin-angiotensin system and increases in circulating Ang II levels and produces upregulation of the number of AT, binding sites in adrenals. 4647 Altogether, these results suggest that the increase in the number of adrenal AT, binding sites is probably caused by increased synthesis of both AT, A and AT, B receptors, but a posttranslational modification cannot be excluded from these studies. The sodium depletioninduced increase in adrenal AT 1A and AT, B mRNA levels, we have observed, can be paralleled to that reported by Iwai et al 10 in total AT, mRNA content under the same conditions but contrasts with the absence of total AT, mRNA modification shown by Kitami et al. 23 However, these authors did not use a quantitative RT-PCR estimation.
Interestingly, the AT 1B receptor mRNA level in the whole adrenal increased more than that of the AT, A receptor. It is known that AT, A mRNA is widely distributed in different parts of the adrenal (zona glomerulosa, zona fasciculata, medulla), whereas AT 1B mRNA is predominant in the zona glomerulosa, as reported by Sandberg et al 20 and Gasc et al. 48 In sodium depletion, Ang II-induced aldosterone production is increased, 49 possibly because of the increased levels of zona glomerulosa AT 1A and AT 1B mRNA. The fact that total adrenal AT 1A mRNA increased less than that of AT, B could be explained by the fact that a sizeable proportion of its distribution is in regions whose Ang Il-mediated functions are not affected by sodium depletion (catecholamine or glucocorticoid secretion). 50 Another application of the present quantitative RT-PCR approach was the study of adrenal AT, receptor subtype mRNA expression in an experimental renovascular model of hypertension. A decrease in AT, B receptor mRNA content was observed, without modification of AT 1A receptor mRNA levels, illustrating a differential pattern of regulation for each receptor subtype. No other reports concerning adrenal AT, receptor mRNA level in this model have yet been published. A single autoradiographic receptor binding study has been published in this model, measuring combined AT, and AT 2 receptors 51 ; these authors reported no change in the adrenal medulla and a 30% increase in the zona glomerulosa. Interestingly, the lack of change in AT, A mRNA content in our study is in agreement with their finding of an unchanged number of Ang II binding sites in the medulla. In contrast, the decrease in AT 1B mRNA, which is mainly expressed in the zona glomerulosa, differs from their results. This difference might be explained by a selective alteration in the transcription rate, by the stability of AT, B mRNA, or by the inability to distinguish between AT, and AT 2 receptors, because it has been shown that this zone contains both receptor types. 39 It is interesting to note that sodium depletion and 2K1C hypertension are two models of renin-angiotensin system stimulation. However, AT, A and AT 1B receptor mRNA levels increased in sodium depletion but not in renovascular hypertension. Although it is difficult to interpret this phenomenon with the data presently available, several tentative hypotheses can be provided: difference in plasma Ang II levels, different hemodynamic states (hypotension versus hypertension), or other neurohumoral factors. The different localization and regulation of these two receptor subtypes are consistent with the possibility that these two receptor subtypes mediate different biological responses of Ang II.
In conclusion, the development of this quantitative RT-PCR approach for quantifying AT, A and AT, B receptor mRNA levels allows the precise determination of their tissue distribution and the regulation of their expression of these receptor transcripts under different pathophysiological conditions. This will enable more precise identification of Ang Il-mediated biological effects and in particular more accurate assessment of which receptor subtypes are involved in a given Ang Il-mediated effect. This approach could be extended to other receptor families, considering the multiplicity of receptor subtypes and their frequent sequence homology.
